KARLA STUMPP: Open Payments
NPI 1336621713 · WESTON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 13 payments from 6 companies in 2025. Trend: 2023 $274 · 2024 $543 · 2025 $1,333
Consulting: $800Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $800 |
| Novo Nordisk Inc | 6 | $275 |
| Dexcom, Inc. | 3 | $175 |
| Corcept Therapeutics | 1 | $39 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| IBSA Pharma Inc. | 1 | $20 |
Products named: TZIELD, Wegovy, Ozempic, DEXCOM G7 GSS (161), Dexcom G6 Transmitter, Korlym, Tirosint.
Industry payments across WI — which companies pay providers there.
